Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

137.64 +1.14 (+0.84%)
Official Closing Price Updated: 7:00 PM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,714,348
Open 137.00
Bid (Size) 137.48 (1)
Ask (Size) 138.01 (1)
Prev. Close 136.50
Today's Range 136.00 - 137.89
52wk Range 131.10 - 168.11
Shares Outstanding N/A
Dividend Yield 3.78%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is AbbVie or Amgen the Better Bargain Buy Right Now?
These elite drugmakers are both working through a number of headwinds. 
Via The Motley Fool
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga

Performance

YTD
-15.24%
-15.24%
1 Month
-6.26%
-6.26%
3 Month
-6.59%
-6.59%
6 Month
-17.08%
-17.08%
1 Year
-7.78%
-7.78%

More News

Read More
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Pharmaceutical Giant Merck Challenges Inflation Reduction Act over Medicare Drug Pricing, Calls It 'Extortion'
Via Benzinga
$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement
Via The Motley Fool
AbbVie Unusual Options Activity
Via Benzinga
Why Is AbbVie Stock Trading Down Today?
Via Benzinga
Why AbbVie and Amgen Are Moving Lower Today
Via The Motley Fool
AbbVie Unusual Options Activity
Via Benzinga
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
Via Investor's Business Daily
7 Best Dividend Stocks to Buy Now in June 2023
Via The Motley Fool
Mark Cuban Helping Lower Cost Of Bestselling Humira With Cost Plus Drug Company: 'The Game Just Changed'
Via Benzinga
2 Dividend Kings on Sale That Are Yielding More Than 4%
Via The Motley Fool
2 Top Dividend Kings to Buy for the Long Haul
Via The Motley Fool
AbbVie Unusual Options Activity
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,200 Today
Via Benzinga
Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Clinical Triumph: MEI Pharma's Voruciclib Demonstrates Encouraging Activity in AML Patients
Via Benzinga
Why Ironwood Pharmaceuticals Stock Bumped Higher Today
Via The Motley Fool
AbbVie Unusual Options Activity
Via Benzinga
VectivBio Stock Catapults 38% After Ironwood Agrees To Buy It For $1 Billion
Via Investor's Business Daily
3 Relatively Safe Stocks to Buy if a Recession Is on the Way
Via The Motley Fool
3 No-Brainer Dividend Stocks to Buy With $1,000 Right Now
Via The Motley Fool
FDA Approves AbbVie/Genmab's Cancer Drug As First Bispecific Antibody For Type Of Lymphoma In Adult Patients
Via Benzinga
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.